Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor vs placebo for stem cell mobilization in multiple myeloma with moderate mobilization
2016-004122-41Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple myeloma (MM) and hematopoietic stem cell mobilization failure comparing Plerixafor + G-CSF arm with Placebo + G-CSF arm (2 arms). Started Mar 2017; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)hematopoietic stem cell mobilization failure
Beyond the preview
Go deeper on 2016-004122-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004122-41.